MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Therapies for Treatment-Resistant Panic Disorder Symptoms

Phase 2

Completed

Conditions: Panic Disorder

Interventions: Drug: Clonazepam
Behavioral: Cognitive behavioral therapy
Drug: Sertraline

First Posted Date: 2005-07-11

Last Posted Date: 2014-06-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 46

Registration Number: NCT00118417

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

Phase 4

Completed

Conditions: Impulse Control Disorders

First Posted Date: 2005-07-11

Last Posted Date: 2008-05-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 75

Registration Number: NCT00118014

Locations: 🇺🇸
Massachusetts General Hospital - OCD Clinic, Charlestown, Massachusetts, United States

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Phase 4

Completed

Conditions: Obsessive Compulsive Disorder

First Posted Date: 2005-06-30

Last Posted Date: 2007-04-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT00116532

Locations: 🇺🇸
Massachusetts General Hospital - OCD Clinic, Charlestown, Massachusetts, United States

Escitalopram for the Treatment of Self-Injurious Skin Picking

Phase 4

Completed

Conditions: Impulse Control Disorders

First Posted Date: 2005-06-21

Last Posted Date: 2008-05-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT00115011

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims

Phase 3

Terminated

Conditions: Anxiety Disorder

First Posted Date: 2005-06-15

Last Posted Date: 2014-06-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT00114374

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Dose-Response of Gonadal Steroids and Bone Turnover in Older Men

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Testosterone
Drug: Goserelin acetate

First Posted Date: 2005-06-14

Last Posted Date: 2019-10-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 177

Registration Number: NCT00114114

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Phase 3

Completed

Conditions: Anxiety Disorder

Interventions: Drug: Duloxetine
Drug: Placebo

First Posted Date: 2005-06-14

Last Posted Date: 2014-06-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 28

Registration Number: NCT00114127

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Phase 2

Terminated

Conditions: Multiple Myeloma
Myelodysplastic Syndrome
Lymphoma
Leukemia

Interventions: Procedure: Non-myeloablative Ex-Vivo T-cell Depleted PBSC Transplant
Procedure: T-cell depleted peripheral blood stem cell transplant

First Posted Date: 2005-06-13

Last Posted Date: 2018-03-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 5

Registration Number: NCT00113828

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Phase 2

Terminated

Conditions: Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia

First Posted Date: 2005-06-10

Last Posted Date: 2018-03-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 14

Registration Number: NCT00113646

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

Phase 4

Completed

Conditions: Anxiety Disorder

Interventions: Drug: Continued Paroxetine CR
Drug: Placebo
Drug: Quetiapine

First Posted Date: 2005-06-08

Last Posted Date: 2014-04-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00113295

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy